Venous leak or veno-occlusive dysfunction (VOD), a common etiological factor contributing to approximately 75% of erectile dysfunction (ED) cases, has traditionally been a complex condition to manage effectively [1]. Recent advancements have seen the development of the ** or leaves it on for extended periods, it can lead to penile ischemia and potentially severe clinical consequences. Management of penile constriction injuries involves the immediate removal of the constricting device to restore blood flow and prevent further tissue damage.
Further research and multicenter trials will be necessary to confirm the potential of this tool and its impact on men affected by ED. The development of the **alla® device, however, highlights the progressive shift in ED therapeutics, aiming not merely to manage ED symptoms but to address the underlying cause and potentially restore erections to their pre-pathological state. Such advancements signal a promising era in ED therapeutics, with the potential to improve patient outcomes and quality of life.
References
Kaba R, Pearce I. Venous leak and erectile dysfunction – an important differential. J Clin Urol. 2020;13:33–9. https://doi.org/10.1177/2051415819847318.
Littlemore AM, Laing L, Bella AJ. 109 evaluation of a FDA and Health Canada compliant novel medical device for improving erectile function across erectile dysfunction etiologies. J Sex Med. 2017;14(Supplement 1):S27–8. https://doi.org/10.1016/j.jsxm.2016.11.062.
Littlemore AM, Laing L, Bella AJ. 106 Salvage of post-prostatectomy injection therapy (with and without venoseal for CVOD) treatment failures by injection therapy coupled with novel silicone loop occlusion device. J Sex Med. 2017;14(Supplement 1):S26–7. https://doi.org/10.1016/j.jsxm.2016.11.059.
Lee J, Hersey K, Lee CT, Fleshner N. Climacturia following radical prostatectomy: prevalence and risk factors. J Urol. 2006;176:2562–5. https://doi.org/10.1016/j.juro.2006.07.158.
Harris E, Llompart D, Izquierdo G, Aziz MA. Patient with penile and scrotal strangulation due to prolonged use of a metal ring device. Cureus. 2020;12:e11928. https://doi.org/10.7759/cureus.11928.
Author information
Authors and Affiliations
Contributions
FAY: project development, manuscript writing. MAMH: project development, manuscript writing. DE: manuscript writing and editing.
Corresponding author
Ethics declarations
Competing interests
DE is a consultant for Boston Scientific, PROCEPT BioRobotics, Olympus, Urotronic, and Prodeon. FAY is a consultant for Coloplast, Acerus, Clarus Therapeutics, and Antares Pharma. MAMH has no disclosures.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yafi, F.A., Hammad, M.A.M. & Elterman, D. **alla®: a novel medical device for addressing erectile dysfunction associated with veno-occlusive dysfunction. Int J Impot Res (2023). https://doi.org/10.1038/s41443-023-00754-w
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41443-023-00754-w
- Springer Nature Limited